What Researchers Did
Researchers conducted a randomized comparative pilot study to evaluate hyperbaric oxygen therapy for maintaining the response to intravesical dimethyl sulfoxide in women with interstitial cystitis/painful bladder syndrome.
What They Found
Out of 20 women with interstitial cystitis/painful bladder syndrome, 14 (70%) experienced clinical improvement after initial dimethyl sulfoxide treatment (p < 0.05). Patients randomized to hyperbaric oxygen therapy in the second phase showed a more substantive and prolonged maintenance of these beneficial effects.
What This Means for Canadian Patients
For Canadian patients suffering from interstitial cystitis/painful bladder syndrome, hyperbaric oxygen therapy might offer a way to extend the relief gained from dimethyl sulfoxide treatments. This could potentially lead to longer periods of reduced pain, urgency, and improved quality of life.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian participants or researchers.
Study Limitations
This was an open, prospective, randomized, comparative pilot study with a small sample size of 20 patients, limiting the generalizability of the findings.